CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 827 of 859
Non-Antibody Products
Page 827 of 859
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Uniconazole | A plant growth regulator that functions by inhibiting CYP707As (Ki = 68 nM… | 10 g | 17852-10 | More Info |
| Uniconazole | A plant growth regulator that functions by inhibiting CYP707As (Ki = 68 nM… | 25 g | 17852-25 | More Info |
| Uniconazole | A plant growth regulator that functions by inhibiting CYP707As (Ki = 68 nM… | 5 g | 17852-5 | More Info |
| Unifiram | A nootropic agent; increases ACh release in the rat cerebral cortex in viv… | 100 mg | 34209-100 | More Info |
| Unifiram | A nootropic agent; increases ACh release in the rat cerebral cortex in viv… | 25 mg | 34209-25 | More Info |
| Unifiram | A nootropic agent; increases ACh release in the rat cerebral cortex in viv… | 250 mg | 34209-250 | More Info |
| Unifiram | A nootropic agent; increases ACh release in the rat cerebral cortex in viv… | 50 mg | 34209-50 | More Info |
| Unoprostone | An agonist of FP receptors (EC50 = 4.12 µM), an active metabolite of… | 1 mg | 16680-1 | More Info |
| Unoprostone | An agonist of FP receptors (EC50 = 4.12 µM), an active metabolite of… | 10 mg | 16680-10 | More Info |
| Unoprostone | An agonist of FP receptors (EC50 = 4.12 µM), an active metabolite of… | 5 mg | 16680-5 | More Info |
| Unoprostone | An agonist of FP receptors (EC50 = 4.12 µM), an active metabolite of… | 50 mg | 16680-50 | More Info |
| Unoprostone isopropyl ester | An ocular hypotensive agent, a prodrug form of unoprostone, and a derivati… | 1 mg | 16681-1 | More Info |
| Unoprostone isopropyl ester | An ocular hypotensive agent, a prodrug form of unoprostone, and a derivati… | 10 mg | 16681-10 | More Info |
| Unoprostone isopropyl ester | An ocular hypotensive agent, a prodrug form of unoprostone, and a derivati… | 5 mg | 16681-5 | More Info |
| Unoprostone isopropyl ester | An ocular hypotensive agent, a prodrug form of unoprostone, and a derivati… | 50 mg | 16681-50 | More Info |
| Untargeted Lipidomics | Our lipid experts offer untargeted lipidomics services to analyze lipid pr… | n/a | n/a | More Info |
| UoS 12258 | A positive allosteric modulator of AMPA receptors; potentiates glutamate-i… | 10 mg | 36571-10 | More Info |
| UoS 12258 | A positive allosteric modulator of AMPA receptors; potentiates glutamate-i… | 5 mg | 36571-5 | More Info |
| UoS 12258 | A positive allosteric modulator of AMPA receptors; potentiates glutamate-i… | 50 mg | 36571-50 | More Info |
| Upadacitinib | A JAK1 inhibitor (IC50 = 47 nM); selective for JAK1 over JAK3 and Tyk2 (IC… | 1 mg | 29706-1 | More Info |
| Upadacitinib | A JAK1 inhibitor (IC50 = 47 nM); selective for JAK1 over JAK3 and Tyk2 (IC… | 10 mg | 29706-10 | More Info |
| Upadacitinib | A JAK1 inhibitor (IC50 = 47 nM); selective for JAK1 over JAK3 and Tyk2 (IC… | 25 mg | 29706-25 | More Info |
| Upadacitinib | A JAK1 inhibitor (IC50 = 47 nM); selective for JAK1 over JAK3 and Tyk2 (IC… | 5 mg | 29706-5 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 1 mg | 17760-1 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 10 mg | 17760-10 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 5 mg | 17760-5 | More Info |
| UPF-1069 | A PARP inhibitor that demonstrates a modest preference for PARP2 over PARP… | 50 mg | 17760-50 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 1 mg | 32860-1 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 10 mg | 32860-10 | More Info |
| UPF-648 | An inhibitor of kynurenine 3-monooxygenase (IC50 = 40 nM); increases kynur… | 5 mg | 32860-5 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 1 mg | 19904-1 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 10 mg | 19904-10 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 25 mg | 19904-25 | More Info |
| Uprosertib | A selective, orally bioavailable inhibitor of Akt (IC50s = 180, 328, and 3… | 5 mg | 19904-5 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 100 g | 26088-100 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 250 g | 26088-250 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 50 g | 26088-50 | More Info |
| Uracil | A pyrimidine nucleoside; a fundamental component of RNA where it binds to… | 500 g | 26088-500 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 1 mg | 33997-1 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 10 mg | 33997-10 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 25 mg | 33997-25 | More Info |
| Uracil-13C,15N2 | An internal standard for the quantification of uracil by GC- or LC-MS | 5 mg | 33997-5 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 10 mg | 36318-10 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 100 mg | 36318-100 | More Info |
| Uracil-d4 | An internal standard for the quantification of uracil by GC- or LC-MS | 50 mg | 36318-50 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 1 g | 29004-1 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 250 mg | 29004-250 | More Info |
| Urapidil (hydrochloride) | An α1-AR antagonist and partial 5-HT1A agonist; selectively binds to… | 500 mg | 29004-500 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 10 mg | 13261-10 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 25 mg | 13261-25 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 5 mg | 13261-5 | More Info |
| URB447 | A CB1 receptor antagonist and CB2 receptor agonist; inhibits the binding o… | 50 mg | 13261-50 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 10 mg | 10046-10 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 100 mg | 10046-100 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 5 mg | 10046-5 | More Info |
| URB597 | A potent and selective inhibitor of FAAH (IC50 = 4.6 nM in brain membranes… | 50 mg | 10046-50 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 10 mg | 10007457-10 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 100 mg | 10007457-100 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 5 mg | 10007457-5 | More Info |
| URB602 | A selective inhibitor of MAGL (IC50 = 28 µM for the rat brain enzyme… | 50 mg | 10007457-50 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 10 mg | 10007691-10 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 100 mg | 10007691-100 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 5 mg | 10007691-5 | More Info |
| URB754 | A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recom… | 50 mg | 10007691-50 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 10 mg | 10674-10 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 100 mg | 10674-100 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 5 mg | 10674-5 | More Info |
| URB937 | A potent FAAH inhibitor (IC50 = 26.8 nM, in vitro; ED50 = 0.2 mg / kg in m… | 50 mg | 10674-50 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 1 mg | 11772-1 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 5 mg | 11772-5 | More Info |
| UR-144-d5 | An internal standard for the quantification of UR-144 by GC- or LC-MS; reg… | 500 µg | 11772-500 | More Info |
| Urdamycin A | A bacterial metabolite; active against a variety of bacteria, but not S. c… | 1 mg | 29510-1 | More Info |
| Urdamycin B | A glycoside bacterial metabolite with antibacterial and anticancer activit… | 1 mg | 29770-1 | More Info |
| UR-144 Degradant | A common impurity observed during GC-MS analysis of samples containing UR-… | 1 mg | 11928-1 | More Info |
| UR-144 Degradant | A common impurity observed during GC-MS analysis of samples containing UR-… | 10 mg | 11928-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile